bazedoxifene has been researched along with Osteoporotic Fractures in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (7.14) | 29.6817 |
| 2010's | 13 (92.86) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lu, H; Luo, Q; Peng, L | 1 |
| Anastasilakis, AD; Makras, P; Yavropoulou, MP | 1 |
| Chines, A; Kaufman, JM; Palacios, S; Silverman, S; Sutradhar, S | 1 |
| Adami, S; Fracassi, E; Gatti, D; Lello, S; Rossini, M; Sblendorio, I; Viapiana, O | 1 |
| Kanis, JA; Kim, K; Luo, X; Sutradhar, S; Svedbom, A | 1 |
| Bushmakin, AG; Ellis, AG; Jansen, JP; Luo, X; Mirkin, S; Reginster, JY; Sutradhar, S; Williams, R | 1 |
| Ohta, H; Solanki, J | 1 |
| Chaki, O | 1 |
| Bobula, J; Lips, P; van Schoor, NM; Yu, H | 1 |
| Borgström, F; Johansson, H; Kanis, JA; Kleman, M; McCloskey, E; Odén, A; Ström, O | 1 |
| Chines, AA; Constantine, GD; Gorai, I; Itabashi, A; Miki, T; Mizunuma, H; Ochi, H; Ohta, H; Sato, H; Sugimoto, T; Takada, M; Yoh, K | 1 |
| Adachi, JD; Chines, AA; Constantine, GD; Felsenberg, D; Kendler, DL; Kung, AW; Mairon, N; Silverman, SL; Teglbjærg, CS | 1 |
| Ben Sedrine, W; Hiligsmann, M; Reginster, JY | 1 |
| Rizzoli, R; Uelbelhart, B | 1 |
4 review(s) available for bazedoxifene and Osteoporotic Fractures
| Article | Year |
|---|---|
Efficacy and safety of bazedoxifene in postmenopausal women with osteoporosis: A systematic review and meta-analysis.
Topics: Bone Density; Bone Density Conservation Agents; Female; Humans; Indoles; Middle Aged; Osteoporosis, Postmenopausal; Osteoporotic Fractures; Randomized Controlled Trials as Topic; Spinal Fractures; Spine; Time Factors; Treatment Outcome | 2017 |
Bazedoxifene for the treatment of osteoporosis.
Topics: Bone Density; Bone Density Conservation Agents; Female; Humans; Indoles; Osteoporosis; Osteoporosis, Postmenopausal; Osteoporotic Fractures; Randomized Controlled Trials as Topic; Selective Estrogen Receptor Modulators; Spinal Fractures | 2019 |
Indirect comparison of bazedoxifene vs oral bisphosphonates for the prevention of vertebral fractures in postmenopausal osteoporotic women.
Topics: Administration, Oral; Bone Density Conservation Agents; Diphosphonates; Female; Humans; Indoles; Osteoporosis, Postmenopausal; Osteoporotic Fractures; Randomized Controlled Trials as Topic; Regression Analysis; Spinal Fractures; Treatment Outcome | 2014 |
Incorporating bazedoxifene into the treatment paradigm for postmenopausal osteoporosis in Japan.
Topics: Bone Density Conservation Agents; Diphosphonates; Female; Humans; Indoles; Osteoporosis, Postmenopausal; Osteoporotic Fractures; Randomized Controlled Trials as Topic; Selective Estrogen Receptor Modulators | 2015 |
4 trial(s) available for bazedoxifene and Osteoporotic Fractures
| Article | Year |
|---|---|
An evaluation of the Fracture Risk Assessment Tool (FRAX®) as an indicator of treatment efficacy: the effects of bazedoxifene and raloxifene on vertebral, nonvertebral, and all clinical fractures as a function of baseline fracture risk assessed by FRAX®.
Topics: Aged; Aged, 80 and over; Algorithms; Bone Density; Bone Density Conservation Agents; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Indoles; Kaplan-Meier Estimate; Lumbar Vertebrae; Middle Aged; Osteoporosis, Postmenopausal; Osteoporotic Fractures; Raloxifene Hydrochloride; Risk Assessment; Spinal Fractures; Treatment Outcome | 2013 |
Cross-geographic region differences in quality of life in women with and without vertebral fracture.
Topics: Aged; Body Mass Index; Bone Density Conservation Agents; Epidemiologic Methods; Female; Humans; Indoles; Middle Aged; Osteoporosis, Postmenopausal; Osteoporotic Fractures; Psychometrics; Quality of Life; Raloxifene Hydrochloride; Spinal Fractures | 2009 |
Effects of bazedoxifene on bone mineral density, bone turnover, and safety in postmenopausal Japanese women with osteoporosis.
Topics: Asian People; Biomarkers; Bone Density; Bone Density Conservation Agents; Bone Remodeling; Demography; Female; Humans; Incidence; Indoles; Japan; Lipid Metabolism; Middle Aged; Osteoporosis, Postmenopausal; Osteoporotic Fractures | 2011 |
Sustained efficacy and safety of bazedoxifene in preventing fractures in postmenopausal women with osteoporosis: results of a 5-year, randomized, placebo-controlled study.
Topics: Aged; Bone Density; Bone Density Conservation Agents; Bone Remodeling; Dose-Response Relationship, Drug; Double-Blind Method; Female; Follow-Up Studies; Humans; Indoles; Middle Aged; Osteoporosis, Postmenopausal; Osteoporotic Fractures; Placebos; Selective Estrogen Receptor Modulators; Spinal Fractures; Treatment Outcome | 2012 |
6 other study(ies) available for bazedoxifene and Osteoporotic Fractures
| Article | Year |
|---|---|
Profile of bazedoxifene/conjugated estrogens for the treatment of estrogen deficiency symptoms and osteoporosis in women at risk of fracture.
Topics: Aged, 80 and over; Bone Density; Bone Remodeling; Clinical Trials as Topic; Estrogens; Estrogens, Conjugated (USP); Female; Humans; Indoles; Middle Aged; Osteoporosis; Osteoporotic Fractures; Quality of Life; Selective Estrogen Receptor Modulators | 2013 |
Comparative cost-effectiveness of bazedoxifene and raloxifene in the treatment of postmenopausal osteoporosis in Europe, using the FRAX algorithm.
Topics: Aged; Algorithms; Bone Density Conservation Agents; Cost-Benefit Analysis; Decision Support Techniques; Dose-Response Relationship, Drug; Europe; Female; Health Care Costs; Health Services Research; Humans; Indoles; Middle Aged; Osteoporosis, Postmenopausal; Osteoporotic Fractures; Quality of Life; Raloxifene Hydrochloride; Risk Assessment; Sensitivity and Specificity | 2014 |
[Selective estrogen receptor modulators (SERMs)].
Topics: Bone Density; Female; Humans; Indoles; Osteoporosis, Postmenopausal; Osteoporotic Fractures; Raloxifene Hydrochloride; Risk Assessment; Selective Estrogen Receptor Modulators | 2015 |
Cost-effectiveness of bazedoxifene incorporating the FRAX® algorithm in a European perspective.
Topics: Aged; Aged, 80 and over; Algorithms; Cost-Benefit Analysis; Europe; Female; Health Care Costs; Humans; Indoles; Markov Chains; Middle Aged; Osteoporosis, Postmenopausal; Osteoporotic Fractures; Quality-Adjusted Life Years; Risk Assessment; Selective Estrogen Receptor Modulators; Treatment Outcome | 2011 |
Cost-effectiveness of bazedoxifene compared with raloxifene in the treatment of postmenopausal osteoporotic women.
Topics: Clinical Trials as Topic; Cost-Benefit Analysis; Female; Humans; Incidence; Indoles; Models, Economic; Osteoporosis, Postmenopausal; Osteoporotic Fractures; Placebos; Raloxifene Hydrochloride; Risk Factors; Treatment Outcome | 2013 |
[Osteoporosis].
Topics: Antibodies, Monoclonal, Humanized; Bone Density Conservation Agents; Calcium; Denosumab; Diphosphonates; Female; Humans; Indoles; Osteoporosis; Osteoporosis, Postmenopausal; Osteoporotic Fractures; Risk Assessment; Teriparatide; Treatment Outcome; Vitamin D | 2012 |